Chronic News and Research

RSS

Absence of Puma and Bim protein leads to autoimmune diseases

Researchers at the Walter and Eliza Hall Institute have discovered that a pair of molecules work together to kill so-called 'self-reactive' immune cells that are programmed to attack the body's own organs.

7 Sep 2012

Small weight gain enough to increase a college student's systolic blood pressure

As a college student, you may be happy simply not to have gained the "Freshman 15." But a University of Illinois study shows that as little as 1.5 pounds per year is enough to raise blood pressure in that age group, and the effect was worse for young women.

7 Sep 2012

Viewpoints: Clinton's rousing support for Medicare, health law; Thalidomide and the struggle for an abortion; Arkansas health innovations

Clinton, once known for the strategy of "triangulation" between the parties, was among the speakers who answered Patrick's call. He assailed Romney and Paul Ryan for falsehoods on welfare and Medicare, dismantling one Tampa argument after another. Offering a vision of "shared responsibilities, shared prosperity [and] a shared sense of community," he stoutly defended Obama's health care law, student loan reforms, rescue of the auto industry, commitments to community colleges and job training, and budget proposals.

7 Sep 2012

Constipation drug may bring US patients relief

The US Food and Drug Administration has approved linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.

6 Sep 2012

Early results of transcatheter valve registry data unveiled

The 1-month follow-up results of the Transcatheter Valve Treatment Sentinel Pilot Registry have provided data on factors associated with transcatheter aortic valve implantation, as well as short-term outcomes, in Europe.

6 Sep 2012

A significant proportion of breast cancer survivors have chronic fatigue

UK study results show that over a third of breast cancer survivors have cancer-related fatigue syndrome and that these women have significantly lower subjective quality of life and mood than their nonfatigued peers.

6 Sep 2012

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso.

6 Sep 2012

Eliminating jnk3 enzyme leads to 90% reduction in Alzheimer's plaque-forming compounds

Scientists have found that eliminating an enzyme from mice with symptoms of Alzheimer's disease leads to a 90 percent reduction in the compounds responsible for formation of the plaques linked to Alzheimer's disease.

6 Sep 2012

Clinical trial to test combination of two drugs in treating fibromyalgia

A chronic pain condition and numerous gastrointestinal disorders may all be caused by a virus. That's a Tuscaloosa-based surgeon's theory likely headed for a clinical trial early next year and one drawing support from a University of Alabama researcher who studies how viruses replicate.

6 Sep 2012

Telaprevir offers advantages in patients with chronic hepatitis C infection of genotype 1

The drug telaprevir has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether telaprevir offers an added benefit compared with the present standard therapy.

6 Sep 2012

Nearly one-third of under-five children malnourished in southern Afghanistan, survey shows

Approximately one-third of children under the age of five in southern Afghanistan, about one million, have acute malnutrition, "with a level of deprivation similar to that found in famine zones, a government survey has found, despite the hundreds of millions of dollars in foreign aid that has been poured into the region," the Guardian reports.

6 Sep 2012

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.

6 Sep 2012

FDA continues review of Salix’s Crofelemer new drug application

Napo Pharmaceuticals, Inc. was informed today that the Food and Drug Administration is continuing its review of the new drug application seeking approval of crofelemer for the treatment of chronic diarrhea in people living with HIV/AIDS on anti-retroviral therapy.

6 Sep 2012

Preeclampsia a significant risk factor for chronic hypertension and hospitalizations later in life

Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic hypertension and hospitalizations later in life.

6 Sep 2012

ACOEM awareness campaign helps employers identify and respond to chronic diseases

The American College of Occupational and Environmental Medicine (ACOEM) today announced a yearlong awareness-building campaign intended to help employers identify and respond to chronic diseases that commonly impact worker health and productivity.

6 Sep 2012

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.

6 Sep 2012

Chronic News and Research

Absence of Puma and Bim protein leads to autoimmune diseases

Small weight gain enough to increase a college student's systolic blood pressure

Viewpoints: Clinton's rousing support for Medicare, health law; Thalidomide and the struggle for an abortion; Arkansas health innovations

Constipation drug may bring US patients relief

Early results of transcatheter valve registry data unveiled

A significant proportion of breast cancer survivors have chronic fatigue

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Eliminating jnk3 enzyme leads to 90% reduction in Alzheimer's plaque-forming compounds

Clinical trial to test combination of two drugs in treating fibromyalgia

Telaprevir offers advantages in patients with chronic hepatitis C infection of genotype 1

Nearly one-third of under-five children malnourished in southern Afghanistan, survey shows

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

FDA continues review of Salix’s Crofelemer new drug application

Preeclampsia a significant risk factor for chronic hypertension and hospitalizations later in life

ACOEM awareness campaign helps employers identify and respond to chronic diseases

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Predictors for pain after breast cancer surgery unveiled

Kidney stones signal poor renal prognosis

Arsenic induces acute promyelocytic leukemia remission

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News